CLINICAL_TRIALS trial_result · 2024-11-18

Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy [Phase 2]

Phase 2 trial evaluating efficacy and safety of givinostat in ambulant Becker muscular dystrophy patients has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Italfarmaco | Conditions: Becker Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2024-11-18